Global Nanomedicines Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Nanotechnology refers to the engineering of functional systems at the molecular scale. It includes construction of items from the bottom up, using modern techniques and tools to make complete, high-performance products. Nanomedicines refer to medications that are based on the application of nanotechnology in the medical field. They include monitoring, construction, repair, and control of human biological systems at the molecular level, using nanodevices and nanostructures.
SCOPE OF THE REPORT:
This report studies the Nanomedicines market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nanomedicines market by product type and applications/end industries.
Factors such as aging populations, increasing prevalence of disorders that could be treated better with nanomedicines, and growing awareness about the availability of alternative treatment using nanomedicines are driving the global nanomedicines market.
North America dominates the global market for nanomedicines due to its large population of senior citizens, leading to an increased demand for improved and efficient medications, and technological advancements in the region. Europe, followed by Asia, is expected to experience high growth rate in the next few years in global nanomedicines market. China and India are expected to be the fastest-growing nanomedicines markets in Asia. Some of the key drivers for the nanomedicines market in emerging countries are the large pool of patients, rising government funding, and increasing research and development in the field of medicine.
The global Nanomedicines market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nanomedicines.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
SCOPE OF THE REPORT:
This report studies the Nanomedicines market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nanomedicines market by product type and applications/end industries.
Factors such as aging populations, increasing prevalence of disorders that could be treated better with nanomedicines, and growing awareness about the availability of alternative treatment using nanomedicines are driving the global nanomedicines market.
North America dominates the global market for nanomedicines due to its large population of senior citizens, leading to an increased demand for improved and efficient medications, and technological advancements in the region. Europe, followed by Asia, is expected to experience high growth rate in the next few years in global nanomedicines market. China and India are expected to be the fastest-growing nanomedicines markets in Asia. Some of the key drivers for the nanomedicines market in emerging countries are the large pool of patients, rising government funding, and increasing research and development in the field of medicine.
The global Nanomedicines market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nanomedicines.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Abbott
- GE Healthcare
- Johnson & Johnson
- Merck
- Pfizer
- CombiMatrix
- Celgene
- Mallinckrodt
- Sigma-Tau Pharmaceuticals
- Teva Pharmaceutical
- Nanosphere
- UCB SA
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Nanoparticles
- Nanoshells
- Nanotubes
- Nanodevices
- Others
- Hospitals
- Clinics
- Research Institute
1 NANOMEDICINES MARKET OVERVIEW
1.1 Product Overview and Scope of Nanomedicines
1.2 Classification of Nanomedicines by Types
1.2.1 Global Nanomedicines Revenue Comparison by Types (2017-2023)
1.2.2 Global Nanomedicines Revenue Market Share by Types in 2017
1.2.3 Nanoparticles
1.2.4 Nanoshells
1.2.5 Nanotubes
1.2.6 Nanodevices
1.2.7 Others
1.3 Global Nanomedicines Market by Application
1.3.1 Global Nanomedicines Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institute
1.4 Global Nanomedicines Market by Regions
1.4.1 Global Nanomedicines Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Nanomedicines Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Nanomedicines Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nanomedicines Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Nanomedicines Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nanomedicines Status and Prospect (2013-2023)
1.5 Global Market Size of Nanomedicines (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Abbott
2.1.1 Business Overview
2.1.2 Nanomedicines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.2 GE Healthcare
2.2.1 Business Overview
2.2.2 Nanomedicines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GE Healthcare Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Nanomedicines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Nanomedicines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Nanomedicines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.6 CombiMatrix
2.6.1 Business Overview
2.6.2 Nanomedicines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 CombiMatrix Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.7 Celgene
2.7.1 Business Overview
2.7.2 Nanomedicines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Celgene Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.8 Mallinckrodt
2.8.1 Business Overview
2.8.2 Nanomedicines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mallinckrodt Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sigma-Tau Pharmaceuticals
2.9.1 Business Overview
2.9.2 Nanomedicines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sigma-Tau Pharmaceuticals Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.10 Teva Pharmaceutical
2.10.1 Business Overview
2.10.2 Nanomedicines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Teva Pharmaceutical Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.11 Nanosphere
2.11.1 Business Overview
2.11.2 Nanomedicines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Nanosphere Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.12 UCB SA
2.12.1 Business Overview
2.12.2 Nanomedicines Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 UCB SA Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL NANOMEDICINES MARKET COMPETITION, BY PLAYERS
3.1 Global Nanomedicines Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Nanomedicines Players Market Share
3.2.2 Top 10 Nanomedicines Players Market Share
3.3 Market Competition Trend
4 GLOBAL NANOMEDICINES MARKET SIZE BY REGIONS
4.1 Global Nanomedicines Revenue and Market Share by Regions
4.2 North America Nanomedicines Revenue and Growth Rate (2013-2018)
4.3 Europe Nanomedicines Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Nanomedicines Revenue and Growth Rate (2013-2018)
4.5 South America Nanomedicines Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Nanomedicines Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA NANOMEDICINES REVENUE BY COUNTRIES
5.1 North America Nanomedicines Revenue by Countries (2013-2018)
5.2 USA Nanomedicines Revenue and Growth Rate (2013-2018)
5.3 Canada Nanomedicines Revenue and Growth Rate (2013-2018)
5.4 Mexico Nanomedicines Revenue and Growth Rate (2013-2018)
6 EUROPE NANOMEDICINES REVENUE BY COUNTRIES
6.1 Europe Nanomedicines Revenue by Countries (2013-2018)
6.2 Germany Nanomedicines Revenue and Growth Rate (2013-2018)
6.3 UK Nanomedicines Revenue and Growth Rate (2013-2018)
6.4 France Nanomedicines Revenue and Growth Rate (2013-2018)
6.5 Russia Nanomedicines Revenue and Growth Rate (2013-2018)
6.6 Italy Nanomedicines Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC NANOMEDICINES REVENUE BY COUNTRIES
7.1 Asia-Pacific Nanomedicines Revenue by Countries (2013-2018)
7.2 China Nanomedicines Revenue and Growth Rate (2013-2018)
7.3 Japan Nanomedicines Revenue and Growth Rate (2013-2018)
7.4 Korea Nanomedicines Revenue and Growth Rate (2013-2018)
7.5 India Nanomedicines Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Nanomedicines Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA NANOMEDICINES REVENUE BY COUNTRIES
8.1 South America Nanomedicines Revenue by Countries (2013-2018)
8.2 Brazil Nanomedicines Revenue and Growth Rate (2013-2018)
8.3 Argentina Nanomedicines Revenue and Growth Rate (2013-2018)
8.4 Colombia Nanomedicines Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE NANOMEDICINES BY COUNTRIES
9.1 Middle East and Africa Nanomedicines Revenue by Countries (2013-2018)
9.2 Saudi Arabia Nanomedicines Revenue and Growth Rate (2013-2018)
9.3 UAE Nanomedicines Revenue and Growth Rate (2013-2018)
9.4 Egypt Nanomedicines Revenue and Growth Rate (2013-2018)
9.5 Nigeria Nanomedicines Revenue and Growth Rate (2013-2018)
9.6 South Africa Nanomedicines Revenue and Growth Rate (2013-2018)
10 GLOBAL NANOMEDICINES MARKET SEGMENT BY TYPE
10.1 Global Nanomedicines Revenue and Market Share by Type (2013-2018)
10.2 Global Nanomedicines Market Forecast by Type (2018-2023)
10.3 Nanoparticles Revenue Growth Rate (2013-2023)
10.4 Nanoshells Revenue Growth Rate (2013-2023)
10.5 Nanotubes Revenue Growth Rate (2013-2023)
10.6 Nanodevices Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)
11 GLOBAL NANOMEDICINES MARKET SEGMENT BY APPLICATION
11.1 Global Nanomedicines Revenue Market Share by Application (2013-2018)
11.2 Nanomedicines Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Research Institute Revenue Growth (2013-2018)
12 GLOBAL NANOMEDICINES MARKET SIZE FORECAST (2018-2023)
12.1 Global Nanomedicines Market Size Forecast (2018-2023)
12.2 Global Nanomedicines Market Forecast by Regions (2018-2023)
12.3 North America Nanomedicines Revenue Market Forecast (2018-2023)
12.4 Europe Nanomedicines Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Nanomedicines Revenue Market Forecast (2018-2023)
12.6 South America Nanomedicines Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Nanomedicines Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Nanomedicines
1.2 Classification of Nanomedicines by Types
1.2.1 Global Nanomedicines Revenue Comparison by Types (2017-2023)
1.2.2 Global Nanomedicines Revenue Market Share by Types in 2017
1.2.3 Nanoparticles
1.2.4 Nanoshells
1.2.5 Nanotubes
1.2.6 Nanodevices
1.2.7 Others
1.3 Global Nanomedicines Market by Application
1.3.1 Global Nanomedicines Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institute
1.4 Global Nanomedicines Market by Regions
1.4.1 Global Nanomedicines Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Nanomedicines Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Nanomedicines Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nanomedicines Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Nanomedicines Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nanomedicines Status and Prospect (2013-2023)
1.5 Global Market Size of Nanomedicines (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Abbott
2.1.1 Business Overview
2.1.2 Nanomedicines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.2 GE Healthcare
2.2.1 Business Overview
2.2.2 Nanomedicines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GE Healthcare Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Nanomedicines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Nanomedicines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Nanomedicines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.6 CombiMatrix
2.6.1 Business Overview
2.6.2 Nanomedicines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 CombiMatrix Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.7 Celgene
2.7.1 Business Overview
2.7.2 Nanomedicines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Celgene Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.8 Mallinckrodt
2.8.1 Business Overview
2.8.2 Nanomedicines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mallinckrodt Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sigma-Tau Pharmaceuticals
2.9.1 Business Overview
2.9.2 Nanomedicines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sigma-Tau Pharmaceuticals Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.10 Teva Pharmaceutical
2.10.1 Business Overview
2.10.2 Nanomedicines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Teva Pharmaceutical Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.11 Nanosphere
2.11.1 Business Overview
2.11.2 Nanomedicines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Nanosphere Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.12 UCB SA
2.12.1 Business Overview
2.12.2 Nanomedicines Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 UCB SA Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL NANOMEDICINES MARKET COMPETITION, BY PLAYERS
3.1 Global Nanomedicines Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Nanomedicines Players Market Share
3.2.2 Top 10 Nanomedicines Players Market Share
3.3 Market Competition Trend
4 GLOBAL NANOMEDICINES MARKET SIZE BY REGIONS
4.1 Global Nanomedicines Revenue and Market Share by Regions
4.2 North America Nanomedicines Revenue and Growth Rate (2013-2018)
4.3 Europe Nanomedicines Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Nanomedicines Revenue and Growth Rate (2013-2018)
4.5 South America Nanomedicines Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Nanomedicines Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA NANOMEDICINES REVENUE BY COUNTRIES
5.1 North America Nanomedicines Revenue by Countries (2013-2018)
5.2 USA Nanomedicines Revenue and Growth Rate (2013-2018)
5.3 Canada Nanomedicines Revenue and Growth Rate (2013-2018)
5.4 Mexico Nanomedicines Revenue and Growth Rate (2013-2018)
6 EUROPE NANOMEDICINES REVENUE BY COUNTRIES
6.1 Europe Nanomedicines Revenue by Countries (2013-2018)
6.2 Germany Nanomedicines Revenue and Growth Rate (2013-2018)
6.3 UK Nanomedicines Revenue and Growth Rate (2013-2018)
6.4 France Nanomedicines Revenue and Growth Rate (2013-2018)
6.5 Russia Nanomedicines Revenue and Growth Rate (2013-2018)
6.6 Italy Nanomedicines Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC NANOMEDICINES REVENUE BY COUNTRIES
7.1 Asia-Pacific Nanomedicines Revenue by Countries (2013-2018)
7.2 China Nanomedicines Revenue and Growth Rate (2013-2018)
7.3 Japan Nanomedicines Revenue and Growth Rate (2013-2018)
7.4 Korea Nanomedicines Revenue and Growth Rate (2013-2018)
7.5 India Nanomedicines Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Nanomedicines Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA NANOMEDICINES REVENUE BY COUNTRIES
8.1 South America Nanomedicines Revenue by Countries (2013-2018)
8.2 Brazil Nanomedicines Revenue and Growth Rate (2013-2018)
8.3 Argentina Nanomedicines Revenue and Growth Rate (2013-2018)
8.4 Colombia Nanomedicines Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE NANOMEDICINES BY COUNTRIES
9.1 Middle East and Africa Nanomedicines Revenue by Countries (2013-2018)
9.2 Saudi Arabia Nanomedicines Revenue and Growth Rate (2013-2018)
9.3 UAE Nanomedicines Revenue and Growth Rate (2013-2018)
9.4 Egypt Nanomedicines Revenue and Growth Rate (2013-2018)
9.5 Nigeria Nanomedicines Revenue and Growth Rate (2013-2018)
9.6 South Africa Nanomedicines Revenue and Growth Rate (2013-2018)
10 GLOBAL NANOMEDICINES MARKET SEGMENT BY TYPE
10.1 Global Nanomedicines Revenue and Market Share by Type (2013-2018)
10.2 Global Nanomedicines Market Forecast by Type (2018-2023)
10.3 Nanoparticles Revenue Growth Rate (2013-2023)
10.4 Nanoshells Revenue Growth Rate (2013-2023)
10.5 Nanotubes Revenue Growth Rate (2013-2023)
10.6 Nanodevices Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)
11 GLOBAL NANOMEDICINES MARKET SEGMENT BY APPLICATION
11.1 Global Nanomedicines Revenue Market Share by Application (2013-2018)
11.2 Nanomedicines Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Research Institute Revenue Growth (2013-2018)
12 GLOBAL NANOMEDICINES MARKET SIZE FORECAST (2018-2023)
12.1 Global Nanomedicines Market Size Forecast (2018-2023)
12.2 Global Nanomedicines Market Forecast by Regions (2018-2023)
12.3 North America Nanomedicines Revenue Market Forecast (2018-2023)
12.4 Europe Nanomedicines Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Nanomedicines Revenue Market Forecast (2018-2023)
12.6 South America Nanomedicines Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Nanomedicines Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Nanomedicines Picture
Table Product Specifications of Nanomedicines
Table Global Nanomedicines and Revenue (Million USD) Market Split by Product Type
Figure Global Nanomedicines Revenue Market Share by Types in 2017
Figure Nanoparticles Picture
Figure Nanoshells Picture
Figure Nanotubes Picture
Figure Nanodevices Picture
Figure Others Picture
Table Global Nanomedicines Revenue (Million USD) by Application (2013-2023)
Figure Nanomedicines Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Research Institute Picture
Table Global Market Nanomedicines Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Nanomedicines Type and Applications
Table Abbott Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table GE Healthcare Basic Information, Manufacturing Base and Competitors
Table GE Healthcare Nanomedicines Type and Applications
Table GE Healthcare Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Nanomedicines Type and Applications
Table Johnson & Johnson Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Nanomedicines Type and Applications
Table Merck Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Nanomedicines Type and Applications
Table Pfizer Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table CombiMatrix Basic Information, Manufacturing Base and Competitors
Table CombiMatrix Nanomedicines Type and Applications
Table CombiMatrix Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Nanomedicines Type and Applications
Table Celgene Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table Mallinckrodt Nanomedicines Type and Applications
Table Mallinckrodt Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Sigma-Tau Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Sigma-Tau Pharmaceuticals Nanomedicines Type and Applications
Table Sigma-Tau Pharmaceuticals Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Nanomedicines Type and Applications
Table Teva Pharmaceutical Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Nanosphere Basic Information, Manufacturing Base and Competitors
Table Nanosphere Nanomedicines Type and Applications
Table Nanosphere Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table UCB SA Basic Information, Manufacturing Base and Competitors
Table UCB SA Nanomedicines Type and Applications
Table UCB SA Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Global Nanomedicines Revenue (Million USD) by Players (2013-2018)
Table Global Nanomedicines Revenue Share by Players (2013-2018)
Figure Global Nanomedicines Revenue Share by Players in 2016
Figure Global Nanomedicines Revenue Share by Players in 2017
Figure Global Top 5 Players Nanomedicines Revenue Market Share in 2017
Figure Global Top 10 Players Nanomedicines Revenue Market Share in 2017
Figure Global Nanomedicines Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Nanomedicines Revenue (Million USD) by Regions (2013-2018)
Table Global Nanomedicines Revenue Market Share by Regions (2013-2018)
Figure Global Nanomedicines Revenue Market Share by Regions (2013-2018)
Figure Global Nanomedicines Revenue Market Share by Regions in 2017
Figure North America Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Europe Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Nanomedicines Revenue and Growth Rate (2013-2018)
Figure South America Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Nanomedicines Revenue and Growth Rate (2013-2018)
Table North America Nanomedicines Revenue by Countries (2013-2018)
Table North America Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure North America Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure North America Nanomedicines Revenue Market Share by Countries in 2017
Figure USA Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Canada Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Mexico Nanomedicines Revenue and Growth Rate (2013-2018)
Table Europe Nanomedicines Revenue (Million USD) by Countries (2013-2018)
Figure Europe Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure Europe Nanomedicines Revenue Market Share by Countries in 2017
Figure Germany Nanomedicines Revenue and Growth Rate (2013-2018)
Figure UK Nanomedicines Revenue and Growth Rate (2013-2018)
Figure France Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Russia Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Italy Nanomedicines Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Nanomedicines Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Nanomedicines Revenue Market Share by Countries in 2017
Figure China Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Japan Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Korea Nanomedicines Revenue and Growth Rate (2013-2018)
Figure India Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Nanomedicines Revenue and Growth Rate (2013-2018)
Table South America Nanomedicines Revenue by Countries (2013-2018)
Table South America Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure South America Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure South America Nanomedicines Revenue Market Share by Countries in 2017
Figure Brazil Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Argentina Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Colombia Nanomedicines Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Nanomedicines Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Nanomedicines Revenue Market Share by Countries in 2017
Figure Saudi Arabia Nanomedicines Revenue and Growth Rate (2013-2018)
Figure UAE Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Egypt Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Nigeria Nanomedicines Revenue and Growth Rate (2013-2018)
Figure South Africa Nanomedicines Revenue and Growth Rate (2013-2018)
Table Global Nanomedicines Revenue (Million USD) by Type (2013-2018)
Table Global Nanomedicines Revenue Share by Type (2013-2018)
Figure Global Nanomedicines Revenue Share by Type (2013-2018)
Figure Global Nanomedicines Revenue Share by Type in 2017
Table Global Nanomedicines Revenue Forecast by Type (2018-2023)
Figure Global Nanomedicines Market Share Forecast by Type (2018-2023)
Figure Global Nanoparticles Revenue Growth Rate (2013-2018)
Figure Global Nanoshells Revenue Growth Rate (2013-2018)
Figure Global Nanotubes Revenue Growth Rate (2013-2018)
Figure Global Nanodevices Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Nanomedicines Revenue by Application (2013-2018)
Table Global Nanomedicines Revenue Share by Application (2013-2018)
Figure Global Nanomedicines Revenue Share by Application (2013-2018)
Figure Global Nanomedicines Revenue Share by Application in 2017
Table Global Nanomedicines Revenue Forecast by Application (2018-2023)
Figure Global Nanomedicines Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Research Institute Revenue Growth Rate (2013-2018)
Figure Global Nanomedicines Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Nanomedicines Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Nanomedicines Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Nanomedicines Revenue Market Forecast (2018-2023)
Figure Europe Nanomedicines Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Nanomedicines Revenue Market Forecast (2018-2023)
Figure South America Nanomedicines Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Nanomedicines Revenue Market Forecast (2018-2023)
Figure Nanomedicines Picture
Table Product Specifications of Nanomedicines
Table Global Nanomedicines and Revenue (Million USD) Market Split by Product Type
Figure Global Nanomedicines Revenue Market Share by Types in 2017
Figure Nanoparticles Picture
Figure Nanoshells Picture
Figure Nanotubes Picture
Figure Nanodevices Picture
Figure Others Picture
Table Global Nanomedicines Revenue (Million USD) by Application (2013-2023)
Figure Nanomedicines Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Research Institute Picture
Table Global Market Nanomedicines Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Nanomedicines Type and Applications
Table Abbott Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table GE Healthcare Basic Information, Manufacturing Base and Competitors
Table GE Healthcare Nanomedicines Type and Applications
Table GE Healthcare Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Nanomedicines Type and Applications
Table Johnson & Johnson Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Nanomedicines Type and Applications
Table Merck Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Nanomedicines Type and Applications
Table Pfizer Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table CombiMatrix Basic Information, Manufacturing Base and Competitors
Table CombiMatrix Nanomedicines Type and Applications
Table CombiMatrix Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Nanomedicines Type and Applications
Table Celgene Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table Mallinckrodt Nanomedicines Type and Applications
Table Mallinckrodt Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Sigma-Tau Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Sigma-Tau Pharmaceuticals Nanomedicines Type and Applications
Table Sigma-Tau Pharmaceuticals Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Nanomedicines Type and Applications
Table Teva Pharmaceutical Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Nanosphere Basic Information, Manufacturing Base and Competitors
Table Nanosphere Nanomedicines Type and Applications
Table Nanosphere Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table UCB SA Basic Information, Manufacturing Base and Competitors
Table UCB SA Nanomedicines Type and Applications
Table UCB SA Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Global Nanomedicines Revenue (Million USD) by Players (2013-2018)
Table Global Nanomedicines Revenue Share by Players (2013-2018)
Figure Global Nanomedicines Revenue Share by Players in 2016
Figure Global Nanomedicines Revenue Share by Players in 2017
Figure Global Top 5 Players Nanomedicines Revenue Market Share in 2017
Figure Global Top 10 Players Nanomedicines Revenue Market Share in 2017
Figure Global Nanomedicines Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Nanomedicines Revenue (Million USD) by Regions (2013-2018)
Table Global Nanomedicines Revenue Market Share by Regions (2013-2018)
Figure Global Nanomedicines Revenue Market Share by Regions (2013-2018)
Figure Global Nanomedicines Revenue Market Share by Regions in 2017
Figure North America Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Europe Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Nanomedicines Revenue and Growth Rate (2013-2018)
Figure South America Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Nanomedicines Revenue and Growth Rate (2013-2018)
Table North America Nanomedicines Revenue by Countries (2013-2018)
Table North America Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure North America Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure North America Nanomedicines Revenue Market Share by Countries in 2017
Figure USA Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Canada Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Mexico Nanomedicines Revenue and Growth Rate (2013-2018)
Table Europe Nanomedicines Revenue (Million USD) by Countries (2013-2018)
Figure Europe Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure Europe Nanomedicines Revenue Market Share by Countries in 2017
Figure Germany Nanomedicines Revenue and Growth Rate (2013-2018)
Figure UK Nanomedicines Revenue and Growth Rate (2013-2018)
Figure France Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Russia Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Italy Nanomedicines Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Nanomedicines Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Nanomedicines Revenue Market Share by Countries in 2017
Figure China Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Japan Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Korea Nanomedicines Revenue and Growth Rate (2013-2018)
Figure India Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Nanomedicines Revenue and Growth Rate (2013-2018)
Table South America Nanomedicines Revenue by Countries (2013-2018)
Table South America Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure South America Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure South America Nanomedicines Revenue Market Share by Countries in 2017
Figure Brazil Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Argentina Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Colombia Nanomedicines Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Nanomedicines Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Nanomedicines Revenue Market Share by Countries in 2017
Figure Saudi Arabia Nanomedicines Revenue and Growth Rate (2013-2018)
Figure UAE Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Egypt Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Nigeria Nanomedicines Revenue and Growth Rate (2013-2018)
Figure South Africa Nanomedicines Revenue and Growth Rate (2013-2018)
Table Global Nanomedicines Revenue (Million USD) by Type (2013-2018)
Table Global Nanomedicines Revenue Share by Type (2013-2018)
Figure Global Nanomedicines Revenue Share by Type (2013-2018)
Figure Global Nanomedicines Revenue Share by Type in 2017
Table Global Nanomedicines Revenue Forecast by Type (2018-2023)
Figure Global Nanomedicines Market Share Forecast by Type (2018-2023)
Figure Global Nanoparticles Revenue Growth Rate (2013-2018)
Figure Global Nanoshells Revenue Growth Rate (2013-2018)
Figure Global Nanotubes Revenue Growth Rate (2013-2018)
Figure Global Nanodevices Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Nanomedicines Revenue by Application (2013-2018)
Table Global Nanomedicines Revenue Share by Application (2013-2018)
Figure Global Nanomedicines Revenue Share by Application (2013-2018)
Figure Global Nanomedicines Revenue Share by Application in 2017
Table Global Nanomedicines Revenue Forecast by Application (2018-2023)
Figure Global Nanomedicines Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Research Institute Revenue Growth Rate (2013-2018)
Figure Global Nanomedicines Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Nanomedicines Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Nanomedicines Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Nanomedicines Revenue Market Forecast (2018-2023)
Figure Europe Nanomedicines Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Nanomedicines Revenue Market Forecast (2018-2023)
Figure South America Nanomedicines Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Nanomedicines Revenue Market Forecast (2018-2023)
